Ignite Creation Date:
2025-12-24 @ 6:36 PM
Ignite Modification Date:
2026-02-04 @ 8:09 AM
Study NCT ID:
NCT01845857
Status:
COMPLETED
Last Update Posted:
2013-05-03
First Post:
2010-08-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A National Study of the Chronic Disease Self-Management Program
Sponsor:
Stanford University
Organization:
Study Overview
Official Title:
A National Study of the Chronic Disease Self-Management Program
Status:
COMPLETED
Status Verified Date:
2010-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This survey will address important research, practice, and policy questions: How does Chronic Disease Self-Management Program (CDSMP) impact participants' general health, their health behaviors, and their need for health care utilization? Who benefits most from the CDSMP program? Are predicted gains maintained over a six and twelve month period? Can critical clinical changes be seen for those who are diabetic?
Detailed Description:
A national survey of participant outcomes is important for documenting how the CDSMP program is impacting people with chronic diseases and influencing health care outcomes. This study will help bridge the research to practice gap and further our knowledge about the outcomes of evidence?based programs that are widely disseminated.
Investigators hope to learn the answers to the following questions for English and Spanish-speaking populations:
1. How does the CDSMP impact a person's general health?
2. Does the CDSMP increase the use of healthful behaviors?
3. Does the CDSMP impact health care utilization?
4. What are the characteristics of those who benefit from the CDSMP?
5. Can these benefits be maintained over 6 and 12 month periods?
6. For people with type 2 diabetes, and hemoglobin A1c be impacted by the CDSMP?
Investigators hope to learn the answers to the following questions for English and Spanish-speaking populations:
1. How does the CDSMP impact a person's general health?
2. Does the CDSMP increase the use of healthful behaviors?
3. Does the CDSMP impact health care utilization?
4. What are the characteristics of those who benefit from the CDSMP?
5. Can these benefits be maintained over 6 and 12 month periods?
6. For people with type 2 diabetes, and hemoglobin A1c be impacted by the CDSMP?
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 18933 IRB Protocol | None | None | View |